SynthesisHealth technology assessment (Winchester, England)2020

Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.

Nigel Armstrong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.